Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4
Kidney International Reports - United States
doi 10.1016/j.ekir.2017.07.004
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2017
Authors
Publisher
Elsevier BV